SUMMARY. Seventeen laboratories in the British Isles participated in a study to compare six different commercially available immunoassays for serum lipoprotein(a) (Lptaj) and to establish reasons for the variations in the measurement of serum Lp(a) concentrations. Pooled serum was distributed neat and after dilution at a central laboratory. In addition, the central laboratory sent unpooled serum sampled monthly from six healthy volunteers to each of the participating laboratories for 12 months.
The assays all gave linear dilution curves which were parallel, although the reported values varied twofold. There were major differences in the values assigned to different manufacturers' calibrants which was not explained by whether the units employed were whole Lp(a), the protein moiety of Lp(a) or simply apolipoprotein(a). The coefficient of variation forthe reported value of Lp(a) over 12 months was 33070. The component variation was 10070 after adjustment for inter-laboratory and intra-laboratory variation. Some individuals clearly had a greater tendency to variable serum Lp(a) concentrations than others, but all the assays responded to this in the same way.
Thus, the assays tested probably measured the same analyte. The problem of calibration could largely be addressed if agreement were reached by the manufacturers. Even with improvements in analytical precision it should be realized that multiple measurements of serum Lp(a) levels are necessary if the true mean value is to be appreciated. Individuals showing wide variation in serum Lp(a) may reward further study if its role is to be established.
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Most case control, and cross-sectional and some prospective studies support the existence of an association between high serum lipoprotein(a) (Lp(a» concentration and coronary heart disease (CHD; reviewed in Ref 1). However, intervention studies are needed to establish whether this association is causal or a consequence of CHD. There is also a need to assess the reliability and performance of the numerous Lp(a) assays available and to develop universal standards and to have a clear view of the analytical and biological variation in serum Lp(a) concentrations. ·On behalf of the British Isles Lp(a) Study Group, Correspondence: Dr M I Mackness, Seasonal variations in serum total cholesterol are well described.? Serum Lp(a) levels may change following physical stress such as surgery,' myocardial infarctiorr-! or the development of renal disease," but short-term changes relating to exercise or viral infection have not so far been described," Generally, however, serum Lp(a) levels are portrayed as largely genetically determined/ and relatively constant being unaffected by diet and many other factors which influence very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL). Nevertheless, evidence does suggest that in some individuals the serum Lp(a) concentration does fluctuate.t-'? but these authors did not attribute this to a true biological variation. 
Immuno-controls
Four control samples (two serum samples and two lyophilized samples) were kindly provided by Immuno Ltd and were distributed to participating laboratories with other samples.
Distribution of samples
Serum from the six volunteers were divided into O' 5 mL aliquots. All samples were coded in Manchester before being posted on the same day of blood sampling to the other participating laboratories. The sample code was only known to the study coordinator (MIM). All assays were, therefore, performed and the results reported blind.
Ninety-six per cent of samples arrived the day after posting and were stored at -20 D C before analysis. Results from samples which did not arrive the day after posting were excluded from the analysis. All assays were performed according to the manufacturer's instructions. The details of antibodies used in each assay and their standardization were kindly provided by the respective manufacturers and are given in Table  2 . All manufacturers maintained that their assay detected all Lp(a) phenotypes. 16 other laboratories which participated in the study.
Subjects
Venous blood was obtained from six healthy male subjects between 0930 hand 1030 h on the first Monday of every calendar month for 1 year. Blood was allowed to clot at 4 DC for 30 min and then centrifuged at 3000 rpm, at 4 DC for 15 min to obtain serum. The Lp(a) phenotype of the volunteers was established using the immunoblotting method;'! The demographic and Lp(a) phenotypic details of the subjects are given in Table 1 .
The serum for distribution in the dilution studies was obtained by pooling serum in equal proportions from four other male subjects.
Dilution studies
Pooled serum was divided into O·5 mL aliquots before dilution and after twofold and fourfold dilutions with either phosphate-buffered saline, 711/0 bovine serum albumin or lipoprotein deficient serum.
MATERIALS AND METHODS
Lipoprotein(a) comprises a LDL particle to which apolipoprotein(a) (apo(a» is proposed to be covalently linked via a disulphide bridge to apolipoprotein B. 11 Apo(a) is similar in structure to plasminogen with a protease domain, kringle 5 and multiple copies of kringle 4 similar to those found in plasminogen. However, apo(a) lacks kringles 1-3 found in plasminogen.'! The size of the apo(a) moiety of Lp(a) (i.e. the number of kringle 4 repeats) is believed to effect the determination of its serum concentration. It has been proposed that all commercially available assays do not react equally with all the different length isoforms of apo(a). 12 The purpose of the present investigation was twofold. First, it was to compare the performance of six different commercial Lp(a) assays available in the UK on a standardized set of samples and secondly to analyse the Lp(a) concentration of six healthy volunteers at monthly intervals for 12 months. Seventeen laboratories throughout the British Isles took part in the study.
Lp(a) assays Six commercially available Lp(a) assays were used by participating laboratories. Four laboratories Other assays Serum total cholesterol was assayed by the enzymic CHOD-PAP method (Biostat, Stockport, Ann Clin Biochem 1996: 33 < 8% from the mean by any method. However, in two of the volunteers this was not the case. Differences in the antibodies employed and the method of standardization between each of the commercial Lp(a) assays methods used are evident from the details provided by the manufacturers (see Table 2 ). These differences inevitably gave rise to apparent differences in Lp(a) concentration reported by various laboratories (see Figs 1-3) for the same sample and would account for some of the variation of different values reported for control populations in the literature. The results of experiments in which dilutions of pooled serum were analysed (Fig. 1) indicated that all the assays had linear dilution curves which were in parallel with one another. The nature of the diluent did not affect the results obtained, PBS, 70/0 BSA and lipoprotein deficient serum all gave similar results (data not shown).
The comparison of monthly Lp(a) values in the six volunteers (Fig. 2 a-e) indicated that in four of the six the Lp(a) concentration fluctuated by In all cases: 0 = subject I; v = subject 2; • = subject 3; " = subject 4; 0 = subject 5; • = subject 6. Points are the means ofall reported values, no outliers were excluded. However, data was excluded where less than 12 values were reported for any individual (d) and (e) with any assay. serum cholesterol (Fig. 4a ) or apolipoprotein B (Fig. 4b) values. Using the method described by Watkin et a/. 15 it is possible to obtain a measure of variation using the 12 monthly figures from all the volunteers. This was calculated by obtaining a mean of all results reported for an individual for each different assay for the 12 month period. The difference between each monthly figure reported and the calculated annual mean was then used to determine the total variation for each assay. The results from all the different assays were combined to determine a mean figure for total variation of an individual's Lp(a) concentration. This indicates that the total variation in Lp(a) over the 12 months of the study was 33l1fo. A large component of this variation was in fact due to a combination of intra-and inter-laboratory variation. This was calculated by obtaining a mean of all the results reported for a particular individual and type of assay on a monthly basis. The difference between each laboratory's reported figure and the calculated mean was then used to determine the laboratory variation for each particular month. At the end of the 12 months each monthly figure for variation was used to determine a mean for that laboratory. The annual mean variation of all the participating centres were then used to produce a global mean figure for inter-laboratory variation, which was 23070. However, 10% of the variation could be attributed to true biological variation. Using these data it is possible to calculate that to get a figure for Lp(a) concentration within 10% of the mean 90% of the time for any individual, Lp(a) must be assayed on at least two separate occasions preferably over 1 month apart. The large inter-laboratory variation even for the same assay when serum Lp(a) was measured was further highlighted in the study when standards provided by Immuno Ltd were circulated to participating laboratories ( Table 3) . The large differences which are apparent from Table 3 were indicative of technical difficulties experienced by some laboratories particularly when large, accurate sample dilutions were required and because in some laboratories staff were unfamiliar with the methods because of the relative infrequency of their use.
DISCUSSION
All the assays compared performed well in dilution experiments over a wide range and their In fact this was not the case, indicating inaccuracy in the assignment of values to calibrants was likely to be the major explanation for the different results with similar specimens in the various assays. Our findings using a different manufacturer's control material (lmmuno) in other assays make it unlikely that a single primary standard could ever be devised which would be suitable for all assay methods. However, the present study does strongly indicate the need for a common secondary standard to be employed in all the assays which would allow a common calibration of the manufacturers' standards. The concentration of Lp(a) in the secondary standard could be established using an assay system in which purified apo(a) behaved similarly to Lp(a) Ann Clin Biochem 1996: 33 in serum. The Pharmacia method in which apo(a) is released by reductive cleavage before immunoassay might be suitable. Apo(a) standard could be prepared from a homozygote for an apo(a) isoform of the most frequently occurring molecular mass.
The present study does not distinguish between intra-and inter-laboratory experimental variation. It does, however, allow an accurate estimate of biological variation in the serum Lp(a) concentration, the coefficient of variation for which averaged 10010. This agrees well with the recent report of Pagani and Panteghini that its biological variation was 7·6% .10, 17 Marcovina and co-workers, as in the present study found the biological variation in serum Lp(a) levels to differ markedly between individuals ranging from as little as 1010 to 51% . 18 It was noteworthy in our study that the volunteer whose Lp(a) level showed the greatest variation was of African rather than European descent, unlike our other volunteers. Serum Lp(a) levelsare typically higher in people of African descent and their frequency distribution tends to be less positively skewed than in Caucasians amongst whom individuals with low levels predominate. 1 The source of the biological variation in the circulating concentration of Lp(a) is not immediately clear. The notion that serum Lp(a) levels are under such tight genetic control that they are relatively constant in each individual is, however, plainly incorrect. They are known to be elevated in minimal change glomerulonephritis and to return to normal when the condition remits." The suggestion has also been made that serum Lp(a) concentration, which correlates with certain indices of inflammation, rise as part of an inflammatory response'? and perhaps even with the development of cardiac ischaemia.! It is possible that the magnitude of the Lp(a) response is genetically determined and ethnic differences suggest that the true biological function of Lp(a) may be conserved in African populations, but that the selective pressure on Lp(a) for preservation of its function has been less in Europe. Regardless of the accuracy of such speculation our findings suggest that several specimens should be analysed from an individual to be confident of the true mean value. One recent report suggests 17 may be required for the average to be within 5l1Jo of the true mean." Certainly, our findings and those of the earlier reports emphasize the uncertainty of reports claiming relatively small fluctuations in serum Lp(a) associated with drug and diet therapy.
